Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
JAMA Cardiol. 2017 Apr 1;2(4):391-399. doi: 10.1001/jamacardio.2016.5493.
Coronary artery calcium (CAC) is associated with coronary heart disease (CHD) and cardiovascular disease (CVD); however, prognostic data on CAC are limited in younger adults.
To determine if CAC in adults aged 32 to 46 years is associated with incident clinical CHD, CVD, and all-cause mortality during 12.5 years of follow-up.
DESIGN, SETTING, AND PARTICIPANTS: The Coronary Artery Risk Development in Young Adults (CARDIA) Study is a prospective community-based study that recruited 5115 black and white participants aged 18 to 30 years from March 25, 1985, to June 7, 1986. The cohort has been under surveillance for 30 years, with CAC measured 15 (n = 3043), 20 (n = 3141), and 25 (n = 3189) years after recruitment. The mean follow-up period for incident events was 12.5 years, from the year 15 computed tomographic scan through August 31, 2014.
Incident CHD included fatal or nonfatal myocardial infarction, acute coronary syndrome without myocardial infarction, coronary revascularization, or CHD death. Incident CVD included CHD, stroke, heart failure, and peripheral arterial disease. Death included all causes. The probability of developing CAC by age 32 to 56 years was estimated using clinical risk factors measured 7 years apart between ages 18 and 38 years.
At year 15 of the study among 3043 participants (mean [SD] age, 40.3 [3.6] years; 1383 men and 1660 women), 309 individuals (10.2%) had CAC, with a geometric mean Agatston score of 21.6 (interquartile range, 17.3-26.8). Participants were followed up for 12.5 years, with 57 incident CHD events and 108 incident CVD events observed. After adjusting for demographics, risk factors, and treatments, those with any CAC experienced a 5-fold increase in CHD events (hazard ratio [HR], 5.0; 95% CI, 2.8-8.7) and 3-fold increase in CVD events (HR, 3.0; 95% CI, 1.9-4.7). Within CAC score strata of 1-19, 20-99, and 100 or more, the HRs for CHD were 2.6 (95% CI, 1.0-5.7), 5.8 (95% CI, 2.6-12.1), and 9.8 (95% CI, 4.5-20.5), respectively. A CAC score of 100 or more had an incidence of 22.4 deaths per 100 participants (HR, 3.7; 95% CI, 1.5-10.0); of the 13 deaths in participants with a CAC score of 100 or more, 10 were adjudicated as CHD events. Risk factors for CVD in early adult life identified those above the median risk for developing CAC and, if applied, in a selective CAC screening strategy could reduce the number of people screened for CAC by 50% and the number imaged needed to find 1 person with CAC from 3.5 to 2.2.
The presence of CAC among individuals aged between 32 and 46 years was associated with increased risk of fatal and nonfatal CHD during 12.5 years of follow-up. A CAC score of 100 or more was associated with early death. Adults younger than 50 years with any CAC, even with very low scores, identified on a computed tomographic scan are at elevated risk of clinical CHD, CVD, and death. Selective use of screening for CAC might be considered in individuals with risk factors in early adulthood to inform discussions about primary prevention.
冠状动脉钙(CAC)与冠心病(CHD)和心血管疾病(CVD)相关;然而,在年轻成年人中,CAC 的预后数据有限。
确定 32 至 46 岁成年人的 CAC 是否与 12.5 年随访期间发生的临床 CHD、CVD 和全因死亡率相关。
设计、地点和参与者:冠状动脉风险发展在年轻人(CARDIA)研究是一项前瞻性的基于社区的研究,从 1985 年 3 月 25 日至 1986 年 6 月 7 日招募了 5115 名年龄在 18 至 30 岁的黑人和白人参与者。该队列已经进行了 30 年的监测,在招募后 15、20 和 25 年分别进行了 CAC 测量(n=3043)、(n=3141)和(n=3189)。事件发生的平均随访期为 12.5 年,从第 15 年计算机断层扫描到 2014 年 8 月 31 日。
包括致命或非致命性心肌梗死、无心肌梗死的急性冠状动脉综合征、冠状动脉血运重建或 CHD 死亡在内的 CHD 事件。CVD 事件包括 CHD、中风、心力衰竭和外周动脉疾病。死亡包括所有原因。使用 18 至 38 岁之间每 7 年测量一次的临床危险因素估计 32 至 56 岁的 CAC 发展概率。
在研究的第 15 年,3043 名参与者(平均[SD]年龄,40.3[3.6]岁;男性 1383 名,女性 1660 名)中,有 309 名(10.2%)有 CAC,Agatston 评分的几何平均值为 21.6(四分位距,17.3-26.8)。参与者随访 12.5 年,观察到 57 例 CHD 事件和 108 例 CVD 事件。调整人口统计学、危险因素和治疗后,任何 CAC 患者的 CHD 事件增加 5 倍(风险比[HR],5.0;95%CI,2.8-8.7),CVD 事件增加 3 倍(HR,3.0;95%CI,1.9-4.7)。在 CAC 评分 1-19、20-99 和 100 或更高的评分中,CHD 的 HR 分别为 2.6(95%CI,1.0-5.7)、5.8(95%CI,2.6-12.1)和 9.8(95%CI,4.5-20.5)。CAC 评分 100 或更高的人每 100 名参与者的死亡率为 22.4 人(HR,3.7;95%CI,1.5-10.0);在 CAC 评分 100 或更高的 13 名死亡者中,有 10 人被判定为 CHD 事件。在成年早期确定的 CVD 危险因素确定了那些处于 CAC 发展中危以上的人群,如果应用于有选择的 CAC 筛查策略,可将需要筛查的人数减少 50%,并将发现 1 名 CAC 患者所需的成像数量从 3.5 减少到 2.2。
32 至 46 岁人群的 CAC 存在与 12.5 年随访期间致命和非致命性 CHD 的风险增加相关。CAC 评分 100 或更高与早逝相关。在计算机断层扫描上发现任何 CAC 的任何 CAC、即使是非常低的分数的年轻 50 岁以下成年人,患临床 CHD、CVD 和死亡的风险都很高。在成年早期有危险因素的个体中,可能会考虑选择性地使用 CAC 筛查,以告知关于一级预防的讨论。